Archives
-
HA mRNA Vaccine Protects Dairy Cows from H5N1
2026-08-24
A hemagglutinin-encoding mRNA vaccine delivered in lipid nanoparticles protected lactating dairy cows from high-dose H5N1 challenge and maintained meaningful protection months after vaccination. The study is important because it evaluates mRNA vaccine safety, immunogenicity, and durability in a clinically and agriculturally relevant large-animal population.
-
WAY-100635 in Pain and 5-HT1A Assays
2026-08-24
WAY-100635 helps separate 5-HT1A receptor signaling from broader serotonergic effects in binding, functional, behavioral, and imaging workflows. This practical guide connects the compound to cannabidiol pain research while emphasizing assay controls, concentration selection, formulation, and interpretation limits.
-
Firefly Luciferase mRNA: A Delivery Stress Test
2026-08-23
Firefly Luciferase mRNA is more than a reporter: it can reveal whether an RNA delivery system achieves cytosolic translation. This article connects Cap1, 5-moUTP, and poly(A)-tail design with practical assay interpretation and the emerging nanoparticle strategy described in Advanced Materials.
-
SARS-CoV-2 Release Factors Revealed by RNAi Screening
2026-08-22
Kerr et al. used an arrayed, druggable-genome RNA interference screen with measurements at two timepoints to identify host factors acting across the SARS-CoV-2 replication and reinfection cycle. The study highlights Rab11a-associated vesicular transport as a conserved proviral pathway and shows that pharmacological disruption with CDKI-73 can prevent viral release, while also defining important limits for interpreting host-targeted antiviral strategies.
-
BMS-345541 hydrochloride: IKK Assay Guide
2026-08-21
BMS-345541 hydrochloride enables selective interrogation of IKK-driven NF-κB signaling in inflammation research while supporting apoptosis and cell-cycle studies in T-cell acute lymphoblastic leukemia. This workflow-focused guide connects cytokine suppression, RIPK1-centered cell-death biology, assay design, and practical troubleshooting.
-
Sulforaphane, ROS, and NLRP3 in Colitis
2026-08-21
A 2024 study identifies sulforaphane as a potential modulator of oxidative stress and NLRP3 inflammasome activation in dextran sodium sulfate-induced mouse colitis. By combining an animal model with RAW264.7 macrophage experiments, the work links reduced reactive oxygen species with lower NLRP3-associated inflammatory signaling while defining important limits for translation to human ulcerative colitis.
-
CGP 55845 hydrochloride in Synaptic Assays
2026-08-20
CGP 55845 hydrochloride provides a selective pharmacological handle for separating GABAB receptor signaling from astrocytic GAT-3-driven effects in dentate gyrus experiments. This workflow-centered guide covers concentration planning, electrophysiology, neurotransmitter release modulation, troubleshooting, and cautious extension into glucose-sensing assays.
-
Tetramethylrhodamine ethyl ester perchlorate Guide
2026-08-20
Tetramethylrhodamine ethyl ester perchlorate enables live-cell measurement of mitochondrial membrane potential by microscopy, flow cytometry, and plate-based fluorescence. This guide connects practical TMRE assay design with trichothecene-induced liver injury, helping distinguish mitochondrial depolarization from broader ROS, caspase-3, and ER stress signals.
-
Palbociclib in Gastric Cancer Assembloid Research
2026-08-19
Palbociclib (PD0332991) is more than a cell-cycle inhibitor in advanced tumor models: it can serve as a functional probe of stromal control over drug response. This article translates patient-derived gastric cancer assembloid findings into practical, context-aware assay strategies.
-
Capsazepine as an MCL1 Inhibitor in Breast Cancer
2026-08-19
The reference study identifies capsazepine as a candidate MCL1 inhibitor capable of restoring tamoxifen sensitivity in resistant breast cancer cells. By combining virtual screening, structural modeling, DARTS-based target validation, and apoptosis assays, the authors connect MCL1 engagement with mitochondrial cell death and provide a rationale for combination endocrine therapy.
-
SR-202 PPAR Antagonist: Research Workflows
2026-08-18
SR-202 gives researchers a selective way to test whether PPARγ drives adipogenesis, insulin resistance, and macrophage-state changes rather than merely correlating with them. This workflow-focused guide connects cell assays, DSS-induced intestinal inflammation models, formulation controls, and troubleshooting for translational metabolic research.
-
Pifithrin-α: A Causal Guide to p53 Assays
2026-08-18
Pifithrin-α is a versatile p53 inhibitor for separating p53-dependent apoptosis from ferroptosis and irradiation responses. This assay-focused guide explains how recent neurotoxicology findings can improve experimental design, controls, and interpretation.
-
OMV-Displayed mRNA Antigens for Tumor Vaccination
2026-08-17
The reference study introduces genetically engineered bacterial outer membrane vesicles (OMVs) that rapidly bind box C/D-tagged mRNA antigens and promote their delivery to dendritic cells. By combining RNA capture, lysosomal escape, and innate immune stimulation in one vesicle platform, the work offers a distinct strategy for personalized mRNA tumor vaccination beyond conventional lipid nanoparticles.
-
Intravesical p21 mRNA-LNP Therapy in Bladder Cancer
2026-08-17
The reference study presents chemically modified p21 mRNA packaged in lipid nanoparticles as a localized tumor suppressor replacement strategy for bladder cancer. Its intravesical delivery model produced bladder-focused expression and antitumor activity in an orthotopic mouse model, while also clarifying the experimental and translational questions that remain before clinical evaluation.
-
Sulfo-NHS-LC-Biotin: Practical Protocol Guide
2026-08-16
Sulfo-NHS-LC-Biotin provides stable, water-compatible biotinylation of primary amines on proteins and intact-cell surface proteins for affinity capture or detection. It is appropriate for permanent extracellular labeling, but not for intracellular or reversible biotinylation workflows.